Intellia Therapeutics Inc (NTLA)
Healthcare
Biotechnology
10.80 $
+0.8%
vs. previous close
Closing price · As of: 3. Aug 2026
Intellia Therapeutics Inc (NTLA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -117 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -90 | -101 | -93 | -121 | -58 | -85 | -85 | -149 | -100 | -77 | -69 | -117 | -363 | |
| 2.2 | 2.3 | 2.5 | 2.5 | 2.6 | 2.6 | 2.6 | 2.5 | 2.5 | 4.9 | 0.4 | 2.2 | 10.0 | |
| 36 | 35 | 35 | 34 | 41 | 40 | 40 | 22 | 22 | 20 | 91 | 13 | 146 | |
| 36 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -5.0 | -14 | 3.1 | -30 | 30 | 9.9 | 2.0 | -59 | -20 | 4.4 | 0.5 | -37 | -52 | |
| 4.3 | 4.3 | 1.5 | 2.5 | 1.0 | 1.3 | 1.0 | 0.7 | 0.2 | 0.0 | 0.1 | 0.1 | 0.5 | |
| -35 | 80 | 46 | 5.9 | -24 | -7.7 | 152 | 94 | 107 | -0.7 | 28 | 66 | 200 | |
| 2.5 | 19 | 106 | 60 | 41 | 82 | 2.3 | 0.0 | 15 | 115 | 2.0 | 34 | 165 | |
| -122 | -2.8 | 59 | -55 | -41 | -10 | 69 | -55 | 22 | 37 | -38 | -21 | 0.5 | |
| -95 | -106 | -95 | -123 | -59 | -86 | -86 | -150 | -100 | -77 | -69 | -117 | -364 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.